A major new report suggests the number of new cancer cases worldwide will increase sharply by the middle of the century, rising from 18.5 million cases in 2023 to 30.5 million in 2050.The team, who ...
Gleevec, a cancer drug first approved for sale in 2001, has dramatically changed the lives of people with chronic myeloid ...